BMJ Paediatrics Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form and are provided with free text boxes to elaborate on their assessment. These free text comments are reproduced below.
GENERAL COMMENTS
The authors describe a care improvement initiative in a large Pakistani hospital. TcB screening of visibly jaundiced otherwise well babies was implemented and clinical characteristics and jaundice-related outcomes were compared in the 6 months before versus the 6 months after the implementation. There was a reduction in the number of bloods taken for TSB quantification following TcB implementation however the proportion of babies receiving PT increased. There is a clear need to address the particularly high incidence of BIND in low-and middle-income countries. Overall this is a useful uncontrolled before-after study, although there are several aspects that require attention, as outlined below.
1-The authors note that the study was approved by an ethics review committee. The name and/or affiliated institution of the committee should be noted. Furthermore, information is missing regarding whether informed consent was required and if so, whether this has been obtained. Table 2 -There is a discrepancy between the gestational age cut-off for inclusion noted in the Methods and in the Table 1 legend.
- 
VERSION 1 -AUTHOR RESPONSE
Reviewer 1 comments:
I confine my remarks to statistical aspects of this paper. These were generally approrpriate, but, in Table 2 -why are there no p values for some comparisons? These should be compared using appropriate models and have the effect sizes and p values added to the text and table
Response: P values added using z test for two sample proportion using STATA software.
Reviewer 2 comments:
1.The authors note that the study was approved by an ethics review committee. The name and/or affiliated institution of the committee should be noted. Furthermore, information is missing regarding whether informed consent was required and if so, whether this has been obtained. This study was a quality improvement initiative which did not require us to take consent from individual subjects
Yes all eligible babies were included 2.Throughout the title, abstract, and manuscript there is too much emphasis on the added value of the 'TcB nomogram for the Pakistani population'. The authors simply used the low-risk line from the AAP nomogram and subtracted 2 mg/dL from this line to account for the underestimation of TSB by TcB. This is not novel nor does this make it a nomogram for the Pakistani population. The emphasis on this nomogram distracts from the main message. The authors should merely describe how they adapted the nomogram to aid implementation of the TcB device. Text highlighting the novelty and/or tailoring of the nomogram to the local situation should be omitted from the title/abstract/main messages/manuscript.
Response: 2. We have amended the emphasis on nomogram in main manuscript.
Using TcB Nomogram with the device makes interpretation and management of neonatal jaundice uniform and easy for all health care providers. We feel this needs to be emphasized.
Amended in manuscript.
3.The authors demonstrate that post-implementation of TcB screening less bloods were taken but more PT was given. It would be extremely helpful to have other indicators evaluated as well to determine added value ad/or safety aspects, such as changes in exchange transfusions, duration of PT, or duration of hospital admission. Accordingly, when describing the Dutch RCT in lines 26-7 on P4, safety aspects should also be noted: yes there were less bloods drawn but was there a difference in safety outcomes?
Response: 3. Although there were no cases of exchange transfusion during the study period, we did not specifically record duration of PT and Hospitalization in our data. Have mentioned this as a shortcomings section of our study. Please find in reviewed manuscript.
4-Discussion:
The authors discuss provide a rough estimate of potential cost savings. They also note that a number of cost aspects were not involved, and that therefore the cost savings are likely to represent an underestimation. A few points:
-Some post-implementation changes may in fact increase costs, such as the 50% increase in phototherapy. This should be noted.
Response: 4. -We think that the increase in PT was due to early detection of babies at risk of significant jaundice by Tcb and hence saved many babies from readmission for PT. same is mentioned in manuscript.
-TcB screening is likely to be cost-saving only in situations were many babies are clustered, such as the authors' institution, given the high costs of the bilirubinometer. This should also be noted.
Following on from these previous points, key message Bc should be weakened.
Response: Well noted and agreed. Most babies are born in Government sector hospitals who will find transcutaneous bilirubin very effective and cost saving. Table 2 Response: Amended in main manuscript -There is a discrepancy between the gestational age cut-off for inclusion noted in the Methods and in the Table 1 legend.
Response: Done in main manuscript - -some typos/missing text parts need to be corrected throughout the manuscript Response: Amended in main manuscript.
Reviewer3:
In the part of introduction you mentioned Kramer scale for screening of hyperbilirubinemia without any exlanation about this screening method,I think its better to explain about that.
